- Home
- BXC vs MRVI Comparison
BXC vs MRVI Comparison
Compare BXC & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BXC
- MRVI
- Stock Information
- Founded
- BXC 2004
- MRVI 2020
- Country
- BXC United States
- MRVI United States
- Employees
- BXC N/A
- MRVI N/A
- Industry
- BXC Wholesale Distributors
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- BXC Consumer Discretionary
- MRVI Health Care
- Exchange
- BXC Nasdaq
- MRVI Nasdaq
- Market Cap
- BXC 1.0B
- MRVI 1.2B
- IPO Year
- BXC 2004
- MRVI 2020
- Fundamental
- Price
- BXC $123.81
- MRVI $4.96
- Analyst Decision
- BXC Strong Buy
- MRVI Buy
- Analyst Count
- BXC 3
- MRVI 11
- Target Price
- BXC $135.67
- MRVI $10.33
- AVG Volume (30 Days)
- BXC 60.5K
- MRVI 2.5M
- Earning Date
- BXC 10-29-2024
- MRVI 11-07-2024
- Dividend Yield
- BXC N/A
- MRVI N/A
- EPS Growth
- BXC N/A
- MRVI N/A
- EPS
- BXC 3.41
- MRVI N/A
- Revenue
- BXC $2,954,424,000.00
- MRVI $276,920,000.00
- Revenue This Year
- BXC N/A
- MRVI N/A
- Revenue Next Year
- BXC $4.71
- MRVI $7.10
- P/E Ratio
- BXC $35.53
- MRVI N/A
- Revenue Growth
- BXC N/A
- MRVI N/A
- 52 Week Low
- BXC $85.98
- MRVI $4.28
- 52 Week High
- BXC $132.67
- MRVI $11.56
- Technical
- Relative Strength Index (RSI)
- BXC 62.45
- MRVI 31.67
- Support Level
- BXC $119.03
- MRVI $4.28
- Resistance Level
- BXC $123.54
- MRVI $5.06
- Average True Range (ATR)
- BXC 4.00
- MRVI 0.46
- MACD
- BXC 0.03
- MRVI -0.16
- Stochastic Oscillator
- BXC 78.44
- MRVI 12.70
About BXC Bluelinx Holdings Inc.
BlueLinx Holdings Inc is engaged in the wholesale distribution of residential and commercial building products. Its business products are split into two categories: Structural products include items such as lumber, plywood, oriented strand board, rebar, and remesh and Specialty products include items such as engineered wood, siding, millwork, outdoor living, specialty lumber and panels, and industrial products. The company's operations are carried out throughout the United States.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.